• Explore /
  • Poster
  • / Seven year update on SOC-1702: A phase 2 study using trabectedin (T) in combination with ipilimumab (I), nivolumab (N) and trabectedin (T) in previously untreated patients with advanced soft tissue sarcoma.

Seven year update on SOC-1702: A phase 2 study using trabectedin (T) in combination with ipilimumab (I), nivolumab (N) and trabectedin (T) in previously untreated patients with advanced soft tissue sarcoma.

Abstract Poster

Authors

Erlinda Gordon

Erlinda Maria Gordon

Sarcoma Oncology Research Center, Santa Monica, CA

Erlinda Maria Gordon , Sant P. Chawla , Nadezhda Omelchenko , Samantha Jeffrey , Anmol Dia Agarwal , Vaishali Kumar , Neal Shiv Chawla , Victoria Chua , Doris V. Quon , Ania Moradkhani , Noah Federman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03138161

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 11577)

DOI

10.1200/JCO.2024.42.16_suppl.11577

Abstract #

11577

Poster Bd #

503

Abstract Disclosures

Similar Posters

First Author: Erlinda Maria Gordon

First Author: Erlinda Maria Gordon

First Author: Sant P. Chawla

First Author: Erlinda Maria Gordon